Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income ▴	Net margin	Return on equity	Revenue growth	Diluted EPS
DERM	Journey Medical Corp Manufacturing · Year ended 2025-12-31 · USD	$61.24M	-$11.43M	-18.7%	-35.9%	11.1%	-$0.47
ALLR	Allarity Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$320.0K	-$11.23M	n/m	-114.3%	n/a	n/a
BHST	Bioharvest Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	$34.51M	-$11.13M	-32.3%	-43.8%	37.0%	n/a
CPMD	Cannapharmarx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.36M	-$11.13M	-817.2%	n/a	66.1%	-$0.02
NRSN	NeuroSense Therapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.12M	n/a	n/a	n/a	-$0.44
SNGX	Soligenix, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.08M	n/a	-209.4%	n/a	-$2.14
AZTR	Azitra, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$10.96M	n/a	-288.2%	-100.0%	-$2.25
ANIX	Anixa Biosciences Inc Manufacturing · Year ended 2025-10-31 · USD	n/a	-$10.93M	n/a	-72.1%	n/a	-$0.34
KPRX	Kiora Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$0	-$10.84M	n/a	-67.2%	-100.0%	-$2.64
PMHS	Polomar Health Services, Inc. Manufacturing · Year ended 2025-12-31 · USD	$648.2K	-$10.70M	n/m	n/a	n/m	-$0.39
BFRI	Biofrontera Inc. Manufacturing · Year ended 2025-12-31 · USD	$41.70M	-$10.54M	-25.3%	-100.5%	11.7%	-$1.04
MIRA	Mira Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.44M	n/a	-100.5%	n/a	-$1.35
TELO	Telomir Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.41M	n/a	-176.1%	n/a	-$0.33
MTNB	Matinas BioPharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.35M	n/a	-214.2%	n/a	-$2.00
HIND	Vyome Holdings, Inc Manufacturing · Year ended 2025-12-31 · USD	$319.7K	-$10.26M	n/m	-272.8%	24.4%	-$4.86
ENSC	Ensysce Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.07M	-$10.18M	-200.8%	-316.6%	-2.8%	-$3.98
OGEN	Oragenics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$9.84M	n/a	-118.9%	n/a	-$4.56
CANF	Can-Fite BioPharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$405.0K	-$9.83M	n/m	-175.8%	-39.9%	-$5.97
LPCN	Lipocine Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.98M	-$9.63M	-487.1%	-66.5%	-82.3%	-$1.69
NNVC	Nanoviricides, Inc. Manufacturing · Year ended 2025-06-30 · USD	$0	-$9.47M	n/a	-125.9%	n/a	-$0.63
CMMB	Chemomab Therapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.99M	n/a	-72.9%	n/a	$0.018
PLYX	Polaryx Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.98M	n/a	-196.8%	n/a	-$0.20
RLYB	Rallybio Corp Manufacturing · Year ended 2025-12-31 · USD	$858.0K	-$8.98M	n/m	-15.5%	34.9%	-$1.59
REVB	Revelation Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.91M	n/a	-100.6%	n/a	-$23.95
VBIO	Valion Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.88M	n/a	-52.9%	n/a	n/a

Rows per page: 2550 100